"The investment community has been asking for specifics on what we possess and here you go," said Michael Hayes, CEO of EPGL. "You have the CEO of a $280 billion company publicly stating that 'Autofocus' contact lens technology is worth $10 to $50 billion annually. EPGL owns key 'Autofocus' technology that is likely to beat Novartis and Google to market. Given that fact, is our present 5 cent per share stock price a bargain right now? Yes I believe it is. Will it remain at this level as the clock ticks at the USPTO? No I do not believe so," added Hayes. "With this news EPGL is going to be discovered by more investors and I believe we may surpass .88 cents or even $1.00+ as our patents pending progress. Current EPGL investors are in at just the right time in my opinion."
What a fraud of a human being,this pathological liar Michael Hayes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.